Antibiotic G-418 was shown to be superior to paromomycin and metronidazole in cecal amoebiasis. Of particular interest was the high degree of activity seen with a relatively short treatment at low levels. Although the antibiotic was trichomonacidal in vitro at low levels, in vivo results indicated that at levels tested the antibiotic did not always affect cures. The antibiotic appears to have promise as an anticestode agent, being more active than paromomycin against Hymenolepis nana and active as a single oral dose at low levels against Taenia spp.
Antibiotic G-418 is a new aminoglycoside antibiotic produced by a new species of Micromonospora. Micromonospora rhodorangea. Details of the isolation, fermentation, and taxonomy of the producing organism have been previously described (14) , as have aspects of its antibacterial activity (16) . This report describes the in vitro and in vivo antiparasitic activity of G-418 against Trichomonas vaginalis, Entamoeba histolytica, Hymenolepis nana, Syphacia obvelata, and Taenia spp.
MATERIALS AND METHODS Antibiotic G-418 was used as the water-soluble sulfate salt. All results are expressed in terms of base activity as determined by microbiological assay. The strain of T. vaginalis used was the Kupferberg strain, originally obtained through the courtesy of Frans Goble, Ciba, and maintained by passage in simplifled Trypticase serum medium containing 5% horse serum. In vitro studies with T. vaginalis were done in this system. Drug-containing media in a volume of 10 ml, as well as controls, were inoculated with T. vaginalis (1.2 x 103 organisms/ml) and incubated at 37 C. Drug effects were determined by counting the number of motile trichomonads after 24 and 48 h of incubation. Culture (0.02 ml) was dispensed under a 22-mm2 cover slip, and the average number of motile trichomonads per low-power field was determined by counting at least 10 low-power fields. The entire cover slip was searched for motile trichomonads before samples were concluded to be negative. Untreated cultures show approximately a 20-to 30-fold multiplication during the test.
The strain of E. histolytica used for in vitro tests was the JH strain obtained through the courtesy of Nathan Entner, New York University Medical Center. E. histolytica was maintained in the modified Shaffer-Frye medium (10) , as a monoaxenic culture with Bacteriodes symbiosis, horse serum, and penicillin, and the in vitro tests employed this system. Tubes containing 10 ml of media, inoculated with 104 amoebae were incubated at 37 C in an anaerobic incubator (10% CO,:90% N2). Tubes were read microscopically every 24 h for a total of 96 h. The number of amoebae growing in each of the tubes was graded from 0 to 4 as follows: 0, no amoebae visible, <500 amoebae/tube; 1, amoebae visible only in the pellicle, about 2,500 amoebae/tube; 2, amoebae visible in the pellicle and a few in adjacent areas, about 15,000 amoebae/tube; 3, amoebae visible in the pellicle with many in the adjacent areas and a few along the test tube wall, about 60,000/tube; 4, amoebae visible in the pellicle and adjacent areas, with many on the test tube wall, about 250,000 amoebae/tube.
Male CF1 mice weighing 20 to 25 g each were used for in vivo evaluation of T. vaginalis. Abscesses were produced by the subcutaneous injection of approximately 4 x 10f trichomonads in a volume of 1 ml. Control animals showed palpable lesions from day 3 or 4 which frequently perforated after day 7. Treatment was given orally, by gavage, starting 4 h after infection and continued daily for 3 days. Mice were sacrificed on day 7, and lesions were graded from 0 to 4 based upon increasing severity. Lesion contents in all mice with 0 to 1 scores were examined microscopically and cultured to see if the mice were actually cured.
The strain of E. histolytica used for in vivo tests was the J-190 (Center for Disease Control) strain obtained from Francis Gregory, Wyeth Laboratories, and was maintained in rats and in modified BoeckDrbholav medium (13) . Chronic cecal amoebiasis was produced in 50-to 70-g Royal Hart male rats. The test procedure was a modification of one previously described (18) . Rats were infected intracecally following laparotomy, using cecal contents and scrapings from previously infected control rats. Treatment was oral starting the day after infection and lasted up to numerous amoebae (3-day treatment). In neither case was any thickening of the cecal wall or lesions seen. In the rats treated with metronidazole, although no lesions were seen at any levels, three had thickened cecal walls and 18 were positive for amoebae. In rats treated with paromomycin at 3.5 mg/kg for 6 days, two had lesions whereas four had thickened cecal walls; at 6.5 mg/kg for 3 days, three had thickened cecal walls whereas at higher levels only amoebae were seen in 11 of 25 rats.
The results of anthelmintic tests with antibiotic G-418 are shown in Table 4 . These indicate 100% activity against both induced tapeworm (H. nana) infections and natural pinworm (S. obvelata) infections, at diet levels as low as 0.06% (74 mg/kg per day) for 5 days, although by gavage the antibiotic does not appear to be as effective. Recent investigations have shown that the antibiotic is 100% effective in cats and dogs against natural Taenia infections at levels as low as 50 mg/kg in a single oral dose. DISCUSSION Some aminoglycoside antibiotics are known to be effective in amoebiasis and trichomoniasis, and against tapeworms. Neomycin was found to be only amoebistatic at high concentrations in vitro (1,000 Mqg/ml) and was also effective in rats only at high doses (13) . Kanamycin under comparable conditions was amoebicicdal at 125 jtg/ml (12) . Streptomycin had very little antiamoebic activity in vitro; however, in vivo it was effective in rats at high doses (8, 13) . Gentamicin also had very little in vitro antiamoebic activity (1) . Paromomycin, on the other hand, has been shown to have excellent antiamoebic activity both in vitro (3.9 to 10 ug/ml) (3, 12) and in vivo (rats, 22 to 44 mg/kg per day for 4 days by gavage) (12) . Metronida- zole is now considered to be a drug of choice in amoebiasis since it is active against all stages of the disease (9) . This is in spite of the fact that the minimal inhibitory concentration in vitro was found to be 25 ,ug/ml, and the median effective dose in rats was found to be 30 mg/kg for 3 days (5). The results of these studies showed that antibiotic G-418 was as effective as paromomycin in vitro and considerably more effective in vivo than both paromomycin and metronidazole in this model of cecal amoebiasis. Of particular interest is the high degree of activity seen with a telatively short (3 day) treatment at low levels, 6 to 10 mg/kg per day. Against T. vaginalis, streptomycin has been shown to be active in vitro only at high levels (17) ; neomycin had either no activity (17) , moderate activity (11), or high activity (7); and paromomycin had moderate activity in vitro and in vivo (12) . Metronidazole in vitro was active at levels of 0.8 (2) to 2.5 Mg/ml (6) and in vivo in subcutaneous infections in mice from 4.5 mg/kg by gavage for 5 days to 40 mg/kg for 4 days (5). Although antibiotic G-418 was trichomonacidal in vitro, most of the mice yielded positive cultures after in vivo trials, indicating a lack of cure with the antibiotic presumably due to low oral absorption.
Paromomycin has been shown to have slight activity against H. nana at levels down to 0.125% in the diet and at 2 g/kg per day by gavage; however, good activity was seen against Hydatigera taeniaeformis in cats in single doses of 250 mg/kg or in 5 daily doses of 50 mg/kg (15 
